S&P 500   2,996.44 (+0.02%)
DOW   26,823.51 (+0.13%)
QQQ   191.48 (-0.20%)
AAPL   241.83 (+0.78%)
FB   184.18 (+1.01%)
MSFT   136.05 (-0.24%)
AMZN   1,750.71 (-0.85%)
CGC   21.35 (+0.95%)
NVDA   193.63 (-1.01%)
MU   44.33 (-0.74%)
BABA   169.20 (-0.41%)
TSLA   252.85 (-1.07%)
T   38.06 (-0.29%)
F   9.02 (-0.55%)
ACB   3.61 (+0.56%)
PRI   125.70 (-0.08%)
NFLX   272.20 (+2.07%)
GILD   65.59 (-0.41%)
DIS   131.64 (-0.58%)
S&P 500   2,996.44 (+0.02%)
DOW   26,823.51 (+0.13%)
QQQ   191.48 (-0.20%)
AAPL   241.83 (+0.78%)
FB   184.18 (+1.01%)
MSFT   136.05 (-0.24%)
AMZN   1,750.71 (-0.85%)
CGC   21.35 (+0.95%)
NVDA   193.63 (-1.01%)
MU   44.33 (-0.74%)
BABA   169.20 (-0.41%)
TSLA   252.85 (-1.07%)
T   38.06 (-0.29%)
F   9.02 (-0.55%)
ACB   3.61 (+0.56%)
PRI   125.70 (-0.08%)
NFLX   272.20 (+2.07%)
GILD   65.59 (-0.41%)
DIS   131.64 (-0.58%)
Log in

Miragen Therapeutics Price Target & Analyst Ratings (NASDAQ:MGEN)

$0.86
0.00 (0.00 %)
(As of 10/23/2019 10:11 AM ET)
Today's Range
$0.81
Now: $0.86
$0.86
50-Day Range
$0.68
MA: $0.89
$1.16
52-Week Range
$0.65
Now: $0.86
$4.96
Volume7,549 shs
Average Volume188,484 shs
Market Capitalization$26.62 million
P/E RatioN/A
Dividend YieldN/A
Beta1.33

Analyst Ratings

Miragen Therapeutics (NASDAQ:MGEN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Miragen Therapeutics in the last 12 months. Their average twelve-month price target is $15.17, suggesting that the stock has a possible upside of 1,668.91%. The high price target for MGEN is $24.00 and the low price target for MGEN is $3.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $15.17$15.17$21.25$21.25
Price Target Upside: 1,668.91% upside1,566.67% upside648.24% upside658.93% upside

Miragen Therapeutics (NASDAQ:MGEN) Consensus Price Target History

Miragen Therapeutics (NASDAQ:MGEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/19/2019HC WainwrightInitiated CoverageBuy$3.00High
5/21/2019WedbushReiterated RatingBuy$24.00Low
1/4/2019Robert W. BairdInitiated CoverageOutperform ➝ OutperformHigh
12/31/2018B. RileyInitiated CoverageBuy ➝ Buy$18.50 ➝ $18.50High
4/9/2018CowenReiterated RatingHoldMedium
3/29/2018Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$14.00Medium
3/22/2018Deutsche BankInitiated CoverageBuy$15.00Medium
3/9/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$19.00Low
1/16/2018Chardan CapitalReiterated RatingBuyLow
1/12/2018OppenheimerInitiated CoverageOutperform$13.00High
(Data available from 10/23/2017 forward)
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel